Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cell Therapy
100%
Chronic Graft-versus-host Disease (cGVHD)
100%
T Cells
36%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
18%
Steroid-refractory
18%
Treg
18%
Graft Engineering
18%
Donor Graft
18%
Disease Progression
9%
Cell-based
9%
Risk Factors
9%
Regulatory T Cells
9%
Immune Recovery
9%
Small Molecules
9%
Host Immune Response
9%
Anti-leukemia
9%
Antimicrobial
9%
Therapeutic Targeting
9%
Disease Mechanisms
9%
Immune Cells
9%
Life-threatening
9%
Mesenchymal Stem Cells
9%
Disease Outcome
9%
Cell Separation
9%
Disease Prevention
9%
GVHD Prophylaxis
9%
Disease Treatment
9%
Adoptive Transfer
9%
Nave
9%
Relapse Rate
9%
Infection Rate
9%
Separation Techniques
9%
Cause of Disease
9%
Major Complications
9%
GVHD Treatment
9%
Host Tissues
9%
Cell Manipulation
9%
Disease Pathophysiology
9%
Graft Manipulation
9%
Cell Reduction
9%
Protein-based Therapeutics
9%
Small Proteins
9%
Immune Modulation
9%
Monocytic Myeloid-derived Suppressor Cells (M-MDSCs)
9%
T Cell Dysfunction
9%
Immune-suppressive
9%
Immune Regulatory
9%
Engineering Techniques
9%
Beneficial Function
9%
Immunology and Microbiology
Acute Graft Versus Host Disease
100%
T Cell
40%
Regulatory T Cell
30%
Graft-Versus-Host Disease
20%
Cell Transplantation
20%
Immunocompetent Cell
20%
Hematopoietic Cell
20%
Steroid
20%
Host Tissue
10%
Immune Reconstitution
10%
Myeloid-Derived Suppressor Cell
10%
T Cell Depletion
10%
Infection Rate
10%
Cell Separation
10%
Mesenchymal Stem Cell
10%
Antimicrobial Agent
10%